Home | Business News | Browse by Publication | P | Pharma Marketletter

Cell Medica treats first patient in CMV IMAPACT trial.

Publication: Pharma Marketletter
Publication Date: 15-SEP-08
Format: Online
Delivery: Immediate Online Access

Article Excerpt
London, UK-based Cell Medica has treated the initial patients in the first-ever study comparing the efficacy of adoptive cell therapy against conventional antiviral drug treatment for cytomegalovirus infections.

The late-stage randomized confirmatory trial is aimed at demonstrating the clinical effectiveness of immunoprophylactic adoptive cellular therapy (IMPACT) for the treatment...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Biocon reports on oral insulin trial., September 15, 2008
Verona to conduct clinical trials of asthma candidate., September 15, 2008
EMEA releases guidelines for Alzheimer's amd Parkson's drugs developme..., September 15, 2008
French govt tackling health over-spend., September 15, 2008
Biotech ambitions of Czech city Brno., September 15, 2008

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.